Durum; Scott
Patent Applications and Registrations
Patent applications and USPTO patent grants for Durum; Scott.The latest application filed is for "il-7r-alpha specific antibodies for treating acute lymphoblastic leukemia".
- Durum; Scott - Frederick MD
| Patent | Date |
|---|---|
| IL-7R-alpha SPECIFIC ANTIBODIES FOR TREATING ACUTE LYMPHOBLASTIC LEUKEMIA App 20220064309 - Durum; Scott ; et al. | 2022-03-03 |
| IL-7R-alpha specific antibodies for treating acute lymphoblastic leukemia Grant 11,111,306 - Durum , et al. September 7, 2 | 2021-09-07 |
| Peptide Hydrogels And Use Thereof App 20210079042 - Schneider; Joel ; et al. | 2021-03-18 |
| Il-7r-alpha Specific Antibodies For Treating Acute Lymphoblastic Leukemia App 20190315875 - Durum; Scott ; et al. | 2019-10-17 |
| IL-7R-alpha specific antibodies for treating acute lymphoblastic leukemia Grant 10,392,441 - Durum , et al. A | 2019-08-27 |
| Il-7r-alpha Specific Antibodies For Treating Acute Lymphoblastic Leukemia App 20180251561 - Durum; Scott ; et al. | 2018-09-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 